ID   LC-99A
AC   CVCL_A1KV
SY   LC99A
DR   Wikidata; Q102114455
RX   PubMed=7671230;
RX   PubMed=9023415;
RX   PubMed=9538136;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01,54:01; C*01:02,12:02 (PubMed=9023415).
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
RX   PubMed=7671230;
RA   Nakao M., Yamana H., Imai Y., Toh Y., Toh U., Kimura A., Yanoma S.,
RA   Kakegawa T., Itoh K.;
RT   "HLA A2601-restricted CTLs recognize a peptide antigen expressed on
RT   squamous cell carcinoma.";
RL   Cancer Res. 55:4248-4252(1995).
//
RX   PubMed=9023415; DOI=10.1006/cimm.1996.1062;
RA   Seki N., Hoshino T., Kikuchi M., Hayashi A., Itoh K.;
RT   "HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating
RT   lymphocytes of patients with non-small cell lung cancer.";
RL   Cell. Immunol. 175:101-110(1997).
//
RX   PubMed=9538136; DOI=10.3892/ijo.12.5.1103;
RA   Takaki T., Hiraki A., Uenaka A., Gomi S., Itoh K., Udono H.,
RA   Shibuya A., Tsuji T., Sekiguchi S., Nakayama E.;
RT   "Variable expression on lung cancer cell lines of HLA-A2-binding MAGE-3
RT   peptide recognized by cytotoxic T lymphocytes.";
RL   Int. J. Oncol. 12:1103-1109(1998).
//